| 
			 | |||||
| 
			 | 
			 | ||||
| 
			 | Topics | ||||
| 
			 | Glioblastoma | Treatment | Targeted therapy | Bevacizumab and other angiogenesis inhibitors | ||||
| 
			 | 
			 | ||||
| 
			 | 
			 | ||||
| 
			 | Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Bevacizumab | ||||
| 
			 | 
			 | ||||
| 
			 | 
			 | ||||
| 
			 | □ OVERVIEW | 
			 | 
			 | ||
| 
			 | 
			 | ||||
| 
			 | 
			 | ||||
| 
			 | □ EFFICACY | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | 
			 | 
			 | |
| 
			 | □ FAILURE | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | |||
| 
			 | 
			 | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | |||
| 
			 | 
			 | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | 
			 | 
			 | |